Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Baseline sputum eosinophil+neutrophil subgroups' clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) Cohort.

Hastie AT, Mauger DT, Denlinger LC, Coverstone A, Castro M, Erzurum S, Jarjour N, Levy BD, Meyers DA, Moore WC, Phillips B, Wenzel SE, Fahy JV, Israel E, Bleecker ER; NHLBI SARP 3 Investigators.

J Allergy Clin Immunol. 2020 Feb 4. pii: S0091-6749(20)30129-9. doi: 10.1016/j.jaci.2020.01.039. [Epub ahead of print]

PMID:
32032631
2.

Safety of repeated hyperpolarized helium 3 magnetic resonance imaging in pediatric asthma patients.

Tsuchiya N, Schiebler ML, Evans MD, Cadman RV, Sorkness RL, Lemanske RF Jr, Jackson DJ, Jarjour NN, Denlinger LC, Fain SB.

Pediatr Radiol. 2020 Jan 24. doi: 10.1007/s00247-019-04604-0. [Epub ahead of print]

PMID:
31980848
3.

Exacerbation-Prone Asthma.

Denlinger LC, Heymann P, Lutter R, Gern JE.

J Allergy Clin Immunol Pract. 2020 Feb;8(2):474-482. doi: 10.1016/j.jaip.2019.11.009. Epub 2019 Nov 22.

PMID:
31765853
4.

Development and initial validation of the Asthma Severity Scoring System (ASSESS).

Fitzpatrick AM, Szefler SJ, Mauger DT, Phillips BR, Denlinger LC, Moore WC, Sorkness RL, Wenzel SE, Gergen PJ, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Israel E, Levy BD, Meyers DA, Teague WG, Bacharier LB, Ly NP, Phipatanakul W, Ross KR, Zein J, Jarjour NN.

J Allergy Clin Immunol. 2020 Jan;145(1):127-139. doi: 10.1016/j.jaci.2019.09.018. Epub 2019 Oct 8.

PMID:
31604088
5.

Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trials.

Grossman NL, Ortega VE, King TS, Bleecker ER, Ampleford EA, Bacharier LB, Cabana MD, Cardet JC, Carr TF, Castro M, Denlinger LC, Denson JL, Fandino N, Fitzpatrick AM, Hawkins GA, Holguin F, Krishnan JA, Lazarus SC, Nyenhuis SM, Phipatanakul W, Ramratnam SK, Wenzel S, Peters SP, Meyers DA, Wechsler ME, Israel E.

J Allergy Clin Immunol. 2019 Dec;144(6):1524-1533. doi: 10.1016/j.jaci.2019.08.033. Epub 2019 Sep 11.

PMID:
31520679
6.

Investigating Fibroblast-Induced Collagen Gel Contraction Using a Dynamic Microscale Platform.

Zhang T, Day JH, Su X, Guadarrama AG, Sandbo NK, Esnault S, Denlinger LC, Berthier E, Theberge AB.

Front Bioeng Biotechnol. 2019 Aug 14;7:196. doi: 10.3389/fbioe.2019.00196. eCollection 2019.

7.

The effect of BPIFA1/SPLUNC1 genetic variation on its expression and function in asthmatic airway epithelium.

Schaefer N, Li X, Seibold MA, Jarjour NN, Denlinger LC, Castro M, Coverstone AM, Teague WG, Boomer J, Bleecker ER, Meyers DA, Moore WC, Hawkins GA, Fahy J, Phillips BR, Mauger DT, Dakhama A, Gellatly S, Pavelka N, Berman R, Di YP, Wenzel SE, Chu HW.

JCI Insight. 2019 Apr 18;4(8). pii: 127237. doi: 10.1172/jci.insight.127237. eCollection 2019 Apr 18.

8.

Unmet Needs in Severe Asthma Subtyping and Precision Medicine Trials. Bridging Clinical and Patient Perspectives.

Siddiqui S, Denlinger LC, Fowler SJ, Akuthota P, Shaw DE, Heaney LG, Brown L, Castro M, Winders TA, Kraft M, Wagers S, Peters MC, Pavord ID, Walker S, Jarjour NN.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):823-829. doi: 10.1164/rccm.201809-1817PP. No abstract available.

PMID:
30726120
9.

Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Fitzpatrick AM, Gillespie SE, Mauger DT, Phillips BR, Bleecker ER, Israel E, Meyers DA, Moore WC, Sorkness RL, Wenzel SE, Bacharier LB, Castro M, Denlinger LC, Erzurum SC, Fahy JV, Gaston BM, Jarjour NN, Larkin A, Levy BD, Ly NP, Ortega VE, Peters SP, Phipatanakul W, Ramratnam S, Teague WG.

J Allergy Clin Immunol. 2019 Jun;143(6):2052-2061. doi: 10.1016/j.jaci.2018.11.022. Epub 2019 Jan 8.

PMID:
30635198
10.

Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial.

Lima JJ, Castro M, King TS, Lang JE, Ortega VE, Peters SP, Denlinger LC, Israel E, Sorkness CA, Wechsler ME, Wenzel SE, Smith LJ.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):444-450.e1. doi: 10.1016/j.anai.2018.06.001. Epub 2018 Jun 14.

11.

Bacterial biogeography of adult airways in atopic asthma.

Durack J, Huang YJ, Nariya S, Christian LS, Ansel KM, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, King TS, White SR, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Peters SP, Smith LJ, Wechsler ME, Lynch SV, Boushey HA; National Heart, Lung and Blood Institute’s “AsthmaNet”.

Microbiome. 2018 Jun 9;6(1):104. doi: 10.1186/s40168-018-0487-3.

12.

ALX receptor ligands define a biochemical endotype for severe asthma.

Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program- Investigators.

JCI Insight. 2018 Mar 22;3(6). pii: 120932. doi: 10.1172/jci.insight.120932. No abstract available.

13.

Complex association patterns for inflammatory mediators in induced sputum from subjects with asthma.

Hastie AT, Steele C, Dunaway CW, Moore WC, Rector BM, Ampleford E, Li H, Denlinger LC, Jarjour N, Meyers DA, Bleecker ER; NHLBI Severe Asthma Research Program (SARP).

Clin Exp Allergy. 2018 Jul;48(7):787-797. doi: 10.1111/cea.13129. Epub 2018 Apr 15.

14.

Lumen area change (Delta Lumen) between inspiratory and expiratory multidetector computed tomography as a measure of severe outcomes in asthmatic patients.

Shim SS, Schiebler ML, Evans MD, Jarjour N, Sorkness RL, Denlinger LC, Rodriguez A, Wenzel S, Hoffman EA, Lin CL, Gierada DS, Castro M, Fain SB; National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

J Allergy Clin Immunol. 2018 Dec;142(6):1773-1780.e9. doi: 10.1016/j.jaci.2017.12.1004. Epub 2018 Feb 10.

15.

Microbial volatile communication in human organotypic lung models.

Barkal LJ, Procknow CL, Álvarez-García YR, Niu M, Jiménez-Torres JA, Brockman-Schneider RA, Gern JE, Denlinger LC, Theberge AB, Keller NP, Berthier E, Beebe DJ.

Nat Commun. 2017 Nov 24;8(1):1770. doi: 10.1038/s41467-017-01985-4.

16.

Regional Heterogeneity of Lobar Ventilation in Asthma Using Hyperpolarized Helium-3 MRI.

Zha W, Kruger SJ, Cadman RV, Mummy DG, Evans MD, Nagle SK, Denlinger LC, Jarjour NN, Sorkness RL, Fain SB.

Acad Radiol. 2018 Feb;25(2):169-178. doi: 10.1016/j.acra.2017.09.014. Epub 2017 Nov 23.

17.

Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma.

Mummy DG, Kruger SJ, Zha W, Sorkness RL, Jarjour NN, Schiebler ML, Denlinger LC, Evans MD, Fain SB.

J Allergy Clin Immunol. 2018 Mar;141(3):1140-1141.e4. doi: 10.1016/j.jaci.2017.10.016. Epub 2017 Nov 10. No abstract available.

18.

Sputum cell IL-1 receptor expression level is a marker of airway neutrophilia and airflow obstruction in asthmatic patients.

Evans MD, Esnault S, Denlinger LC, Jarjour NN.

J Allergy Clin Immunol. 2018 Aug;142(2):415-423. doi: 10.1016/j.jaci.2017.09.035. Epub 2017 Dec 26.

19.

Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control.

Wong-McGrath K, Denlinger LC, Bleecker ER, Castro M, Gaston B, Israel E, Jarjour NN, Mauger DT, Peters S, Phillips BR, Wenzel SE, Fahy JV, Peters MC; National Heart Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators.

Chest. 2018 Feb;153(2):378-386. doi: 10.1016/j.chest.2017.10.017. Epub 2017 Oct 26.

20.

Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.

Teague WG, Phillips BR, Fahy JV, Wenzel SE, Fitzpatrick AM, Moore WC, Hastie AT, Bleecker ER, Meyers DA, Peters SP, Castro M, Coverstone AM, Bacharier LB, Ly NP, Peters MC, Denlinger LC, Ramratnam S, Sorkness RL, Gaston BM, Erzurum SC, Comhair SAA, Myers RE, Zein J, DeBoer MD, Irani AM, Israel E, Levy B, Cardet JC, Phipatanakul W, Gaffin JM, Holguin F, Fajt ML, Aujla SJ, Mauger DT, Jarjour NN.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):545-554.e4. doi: 10.1016/j.jaip.2017.05.032. Epub 2017 Aug 31.

21.

Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.

Kelly EA, Esnault S, Liu LY, Evans MD, Johansson MW, Mathur S, Mosher DF, Denlinger LC, Jarjour NN.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1385-1395. doi: 10.1164/rccm.201611-2234OC.

22.

ALX receptor ligands define a biochemical endotype for severe asthma.

Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators.

JCI Insight. 2017 Jul 20;2(14). pii: 93534. doi: 10.1172/jci.insight.93534. eCollection 2017 Jul 20. Erratum in: JCI Insight. 2018 Mar 22;3(6):.

23.

Epstein-Barr Virus-induced Gene 2 Mediates Allergen-induced Leukocyte Migration into Airways.

Shen ZJ, Hu J, Kashi VP, Kelly EA, Denlinger LC, Lutchman K, McDonald JG, Jarjour NN, Malter JS.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1576-1585. doi: 10.1164/rccm.201608-1580OC.

24.

Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment.

Durack J, Lynch SV, Nariya S, Bhakta NR, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, Sharp-King T, White SR, Woodruff PG, Avila PC, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Moore WC, Peters SP, Que L, Smith LJ, Sorkness CA, Wechsler ME, Wenzel SE, Boushey HA, Huang YJ; National Heart, Lung and Blood Institute's “AsthmaNet”.

J Allergy Clin Immunol. 2017 Jul;140(1):63-75. doi: 10.1016/j.jaci.2016.08.055. Epub 2016 Nov 10.

25.

Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.

Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, Castro M, Peters SP, Phipatanakul W, Aujla S, Bacharier LB, Bleecker ER, Comhair SA, Coverstone A, DeBoer M, Erzurum SC, Fain SB, Fajt M, Fitzpatrick AM, Gaffin J, Gaston B, Hastie AT, Hawkins GA, Holguin F, Irani AM, Israel E, Levy BD, Ly N, Meyers DA, Moore WC, Myers R, Opina MT, Peters MC, Schiebler ML, Sorkness RL, Teague WG, Wenzel SE, Woodruff PG, Mauger DT, Fahy JV, Jarjour NN; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program-3 Investigators.

Am J Respir Crit Care Med. 2017 Feb 1;195(3):302-313. doi: 10.1164/rccm.201602-0419OC. Erratum in: Am J Respir Crit Care Med. 2018 Apr 1;197(7):971.

26.

Vitamin D Supplementation and the Risk of Colds in Patients with Asthma.

Denlinger LC, King TS, Cardet JC, Craig T, Holguin F, Jackson DJ, Kraft M, Peters SP, Ross K, Sumino K, Boushey HA, Jarjour NN, Wechsler ME, Wenzel SE, Castro M, Avila PC; NHLBI AsthmaNet Investigators.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):634-41. doi: 10.1164/rccm.201506-1169OC.

27.

Future Research Directions in Asthma. An NHLBI Working Group Report.

Levy BD, Noel PJ, Freemer MM, Cloutier MM, Georas SN, Jarjour NN, Ober C, Woodruff PG, Barnes KC, Bender BG, Camargo CA Jr, Chupp GL, Denlinger LC, Fahy JV, Fitzpatrick AM, Fuhlbrigge A, Gaston BM, Hartert TV, Kolls JK, Lynch SV, Moore WC, Morgan WJ, Nadeau KC, Ownby DR, Solway J, Szefler SJ, Wenzel SE, Wright RJ, Smith RA, Erzurum SC.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1366-72. doi: 10.1164/rccm.201505-0963WS. Review.

28.

Severity of virus-induced asthma symptoms is inversely related to resolution IFN-λ expression.

Schwantes EA, Denlinger LC, Evans MD, Gern JE, Jarjour NN, Mathur SK.

J Allergy Clin Immunol. 2015 Jun;135(6):1656-9. doi: 10.1016/j.jaci.2015.01.038. Epub 2015 Mar 14. No abstract available.

29.

Cholesterol selectively regulates IL-5 induced mitogen activated protein kinase signaling in human eosinophils.

Burnham ME, Esnault S, Roti Roti EC, Bates ME, Bertics PJ, Denlinger LC.

PLoS One. 2014 Aug 14;9(8):e103122. doi: 10.1371/journal.pone.0103122. eCollection 2014.

30.

Nasal lavage VEGF and TNF-α levels during a natural cold predict asthma exacerbations.

Manthei DM, Schwantes EA, Mathur SK, Guadarrama AG, Kelly EA, Gern JE, Jarjour NN, Denlinger LC.

Clin Exp Allergy. 2014 Dec;44(12):1484-93. doi: 10.1111/cea.12387.

31.

Differential requirement for P2X7R function in IL-17 dependent vs. IL-17 independent cellular immune responses.

Sullivan JA, Jankowska-Gan E, Shi L, Roenneburg D, Hegde S, Greenspan DS, Wilkes DS, Denlinger LC, Burlingham WJ.

Am J Transplant. 2014 Jul;14(7):1512-22. doi: 10.1111/ajt.12741. Epub 2014 May 27.

32.

Allergen challenge in vivo alters rhinovirus-induced chemokine secretion from human airway macrophages.

Karta MR, Wickert LE, Curran CS, Gavala ML, Denlinger LC, Gern JE, Bertics PJ.

J Allergy Clin Immunol. 2014 Apr;133(4):1227-1230.e4. doi: 10.1016/j.jaci.2014.01.003. Epub 2014 Feb 14. No abstract available.

33.

Interferon gene expression in sputum cells correlates with the Asthma Index Score during virus-induced exacerbations.

Schwantes EA, Manthei DM, Denlinger LC, Evans MD, Gern JE, Jarjour NN, Mathur SK.

Clin Exp Allergy. 2014 Jun;44(6):813-21. doi: 10.1111/cea.12269.

34.

Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5 family cytokines.

Esnault S, Kelly EA, Johansson MW, Liu LY, Han ST, Akhtar M, Sandbo N, Mosher DF, Denlinger LC, Mathur SK, Malter JS, Jarjour NN.

Clin Immunol. 2014 Jan;150(1):90-100. doi: 10.1016/j.clim.2013.11.009. Epub 2013 Nov 23.

35.

Predictors of response to tiotropium versus salmeterol in asthmatic adults.

Peters SP, Bleecker ER, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Craig T, Denlinger LC, Engle LL, Dimango EA, Israel E, Kraft M, Lazarus SC, Lemanske RF Jr, Lugogo N, Martin RJ, Meyers DA, Ramsdell J, Sorkness CA, Sutherland ER, Wasserman SI, Walter MJ, Wechsler ME, Chinchilli VM, Szefler SJ; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

J Allergy Clin Immunol. 2013 Nov;132(5):1068-1074.e1. doi: 10.1016/j.jaci.2013.08.003. Epub 2013 Sep 29.

36.

Human airway eosinophils exhibit preferential reduction in STAT signaling capacity and increased CISH expression.

Burnham ME, Koziol-White CJ, Esnault S, Bates ME, Evans MD, Bertics PJ, Denlinger LC.

J Immunol. 2013 Sep 15;191(6):2900-6. doi: 10.4049/jimmunol.1300297. Epub 2013 Aug 16.

37.

Nucleotide receptor P2RX7 stimulation enhances LPS-induced interferon-β production in murine macrophages.

Gavala ML, Liu YP, Lenertz LY, Zeng L, Blanchette JB, Guadarrama AG, Denlinger LC, Bertics PJ, Smith JA.

J Leukoc Biol. 2013 Oct;94(4):759-68. doi: 10.1189/jlb.0712351. Epub 2013 Aug 2.

38.

Markers of vascular perturbation correlate with airway structural change in asthma.

Johansson MW, Kruger SJ, Schiebler ML, Evans MD, Sorkness RL, Denlinger LC, Busse WW, Jarjour NN, Montgomery RR, Mosher DF, Fain SB.

Am J Respir Crit Care Med. 2013 Jul 15;188(2):167-78. doi: 10.1164/rccm.201301-0185OC.

39.

Identification of genes expressed by human airway eosinophils after an in vivo allergen challenge.

Esnault S, Kelly EA, Schwantes EA, Liu LY, DeLain LP, Hauer JA, Bochkov YA, Denlinger LC, Malter JS, Mathur SK, Jarjour NN.

PLoS One. 2013 Jul 2;8(7):e67560. doi: 10.1371/journal.pone.0067560. Print 2013.

40.

The C-terminus of human nucleotide receptor P2X7 is critical for receptor oligomerization and N-linked glycosylation.

Wickert LE, Blanchette JB, Waldschmidt NV, Bertics PJ, Denu JM, Denlinger LC, Lenertz LY.

PLoS One. 2013 May 14;8(5):e63789. doi: 10.1371/journal.pone.0063789. Print 2013.

41.

Anti-IL-5 attenuates activation and surface density of β(2) -integrins on circulating eosinophils after segmental antigen challenge.

Johansson MW, Gunderson KA, Kelly EA, Denlinger LC, Jarjour NN, Mosher DF.

Clin Exp Allergy. 2013 Mar;43(3):292-303. doi: 10.1111/j.1365-2222.2012.04065.x.

42.

Safety of and cellular response to segmental bronchoprovocation in allergic asthma.

Denlinger LC, Kelly EA, Dodge AM, McCartney JG, Meyer KC, Cornwell RD, Jackson MJ, Evans MD, Jarjour NN.

PLoS One. 2013;8(1):e51963. doi: 10.1371/journal.pone.0051963. Epub 2013 Jan 16.

43.

P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy.

Denlinger LC, Manthei DM, Seibold MA, Ahn K, Bleecker E, Boushey HA, Calhoun WJ, Castro M, Chinchili VM, Fahy JV, Hawkins GA, Icitovic N, Israel E, Jarjour NN, King T, Kraft M, Lazarus SC, Lehman E, Martin RJ, Meyers DA, Peters SP, Sheerar D, Shi L, Sutherland ER, Szefler SJ, Wechsler ME, Sorkness CA, Lemanske RF Jr; NHLBI Asthma Clinical Research Network Investigators.

Am J Respir Crit Care Med. 2013 Jan 1;187(1):28-33. doi: 10.1164/rccm.201204-0750OC. Epub 2012 Nov 9.

44.

Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function.

Manthei DM, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Gern JE, Lemanske RF Jr, Denlinger LC.

J Allergy Clin Immunol. 2012 Aug;130(2):496-502. doi: 10.1016/j.jaci.2012.05.040. Epub 2012 Jun 27.

45.

Key observations from the NHLBI Asthma Clinical Research Network.

Szefler SJ, Chinchilli VM, Israel E, Denlinger LC, Lemanske RF Jr, Calhoun W, Peters SP; National Heart, Lung and Blood Institute Asthma Clinical Research Network.

Thorax. 2012 May;67(5):450-5. doi: 10.1136/thoraxjnl-2012-201876. Review.

46.

Rhinovirus-induced IL-1β release from bronchial epithelial cells is independent of functional P2X7.

Shi L, Manthei DM, Guadarrama AG, Lenertz LY, Denlinger LC.

Am J Respir Cell Mol Biol. 2012 Sep;47(3):363-71. doi: 10.1165/rcmb.2011-0267OC. Epub 2012 Apr 5.

47.

Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.

Denlinger LC, Sorkness RL, Lee WM, Evans MD, Wolff MJ, Mathur SK, Crisafi GM, Gaworski KL, Pappas TE, Vrtis RF, Kelly EA, Gern JE, Jarjour NN.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1007-14. doi: 10.1164/rccm.201103-0585OC.

48.

Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

J Allergy Clin Immunol. 2011 Feb;127(2):372-381.e1-3. doi: 10.1016/j.jaci.2010.10.048. Epub 2010 Dec 30.

49.

Role of infection in the development and exacerbation of asthma.

Guilbert TW, Denlinger LC.

Expert Rev Respir Med. 2010 Feb;4(1):71-83. doi: 10.1586/ers.09.60. Review.

50.

Detecting gene-by-smoking interactions in a genome-wide association study of early-onset coronary heart disease using random forests.

Maenner MJ, Denlinger LC, Langton A, Meyers KJ, Engelman CD, Skinner HG.

BMC Proc. 2009 Dec 15;3 Suppl 7:S88.

Supplemental Content

Loading ...
Support Center